Asymmetric Structure-Driven Functional Synergy: A Multistimuli-Activated Janus Nanomotor for Self-Amplifying NO Cascade Therapy 

Chengcheng Li et al.

Adv Sci (Weinh). 2026 Sep 27:e77848. doi: 10.1002/advs.77848. Online ahead of print.

Published on September 27, 2026

Abstract

ABSTRACT

Nitric oxide (NO)-based cancer therapy is fundamentally limited by poor intratumoral penetration of exogenous donors and their inability to sustain localized relevant flux. Here, a multistimuli-activated Janus nanomotor was developed to interconnect nonenzymatic and enzymatic NO-generation pathways, enabling in situ self-cascading NO production. The nanomotor comprises an AuPt3Cu nanozyme asymmetrically coated with a disulfide-bridged mesoporous silica shell (2sMSN) loaded with L-arginine, allowing autonomous propulsion under O2, NO, and NIR irradiation to achieve deep tumor penetration. Upon cellular internalization, the asymmetric architecture enables concurrent AuPt3Cu-catalyzed oxidation of glucose to H2O2 and GSH-responsive degradation of 2sMSN to release L-arginine, thereby coupling nonenzymatic NO generation through H2O2-mediated L-arginine oxidation. Subsequently, the resulting nitrosative stress suppresses glycolysis and drives compensatory pentose phosphate pathway activation, thereby increasing cofactor availability and enhancing nitric oxide synthase-dependent NO production. This self-amplifying NO loop further amplifies mild photothermal therapy by inducing HSP90 downregulation, thereby triggering immunogenic cell death and achieving effective melanoma clearance. Overall, this Janus nanomotor presents an "asymmetric structure-driven functional synergy" strategy for controllable, sustained, and uniform NO generation, offering a distinctive paradigm to overcome the intrinsic penetration and sustainability limitations of gas-based therapeutic modalities.

PMID:42801585 | PMC:PMC13616278 | DOI:10.1002/advs.77848

 Read More

← Back to Publications
Mikkola Lea et al.Biochem Biophys Rep. 2026 Nov 9;48:102875. doi: 10.1016/j.bbrep.2026.102875. eCollection 2026 Dec.
Gautier Follain et al.Bio Protoc. 2026 Nov 5;16(21):e5861. doi: 10.21769/BioProtoc.5861. eCollection 2026 Nov 5.
Francesca Bottanelli et al.J Cell Sci. 2026 Nov 1;139(21):jcs265433. doi: 10.1242/jcs.265433. Epub 2026 Nov 12.
Aliaa E Ali et al.Hum Mutat. 2026 Nov 8;2026:8234670. doi: 10.1155/humu/8234670. eCollection 2026.
Marie Christine Goess et al.J Crohns Colitis. 2026 Nov 7;20(11):jjag182. doi: 10.1093/ecco-jcc/jjag182.